In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind
All three programs in this comparison let you communicate with the prescribing clinician through their platform, so you can report side effects and adjust dose without paying for an extra visit
A prospective study of transsulfuration biomarkers in autistic disorders
At every step, companies must ensure product quality and regulatory compliance
Fuels Your Mitochondria: Your mitochondria are the "power plants" in your cells
Two peptides anchor almost every tissue-repair study in this category: BPC-157 and TB-500